Page:United States Statutes at Large Volume 107 Part 1.djvu/182

 107 STAT. 156 PUBLIC LAW 103-43—JUNE 10, 1993 to the extent that such Institutes and agencies have responsibilities that are related to prostate cancer. " (c) PROGRAMS.— "(1) IN GENERAL.— In carrying out subsection (a), the Director of the Institute shall conduct or support research to expand the understanding of the cause of, and to find a cure for, prostate cancer. Activities under such subsection shall provide for an expansion and intensification of the conduct and support of— "(A) basic research concerning the etiology and causes of prostate cancer; "(B) clinical research and related activities concerning the causes, prevention, detection and treatment of prostate cancer; "(C) prevention and control and early detection programs with respect to prostate cancer in accordance with section 412, particularly as it relates to intensifying research on the role of prostate specific antigen for the screening and early detection of prostate cancer; "(D) an Inter-Institute Task Force, under the direction of the Director of the Institute, to provide coordination between relevant National Institutes of Health components of research efforts on prostate cancer; "(E) control programs with respect to prostate cancer in accordance with section 412; "(F) information and education programs with respect to prostate cancer in accordance with section 413; and "(G) research and demonstration centers with respect to prostate cancer in accordance with section 414, including the development and operation of centers for prostate cancer research to bring together basic and clinical, biomedical and behavioral scientists to conduct basic, clinical, epidemiological, psychosocial, prevention and control, treatment, research, and related activities on prostate cancer. Not less than six centers shall be operated under subparagraph (G). Activities of such centers should include supporting new and innovative research and training programs for new researchers. Such centers shall give priority to expediting the transfer of research advances to clinical applications. " (2) IMPLEMENTATION OF PLAN FOR PROGRAMS. — "(A) The Director of the Institute shall ensure that the research programs described in paragraph (1) are implemented in accordance with a plan for the programs. Such plan shall include comments and recommendations that the Director of the Institute considers appropriate, with due consideration provided to the professional judgment needs of the Institute as expressed in the annual budget estimate prepared in accordance with section 413(9). The Director of the Institute, in consultation with the National Cancer Advisory Board, shall periodically review and revise such plan. "(B) Not later than October 1, 1993, the Director of the Institute shall submit a copy of the plan to the President's Cancer Panel, the Secretary, and the Director of NIH.

�